z-logo
open-access-imgOpen Access
Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure forHelicobacter pyloriinfection
Author(s) -
Ji Hyun Lim,
Dong Hoon Lee,
Seong tae Lee,
Nayoung Kim,
Young Soo Park,
Cheol Min Shin,
In Sung Song
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i46.13124
Subject(s) - medicine , helicobacter pylori , moxifloxacin , urea breath test , gastroenterology , amoxicillin , breath test , adverse effect , rabeprazole , combination therapy , surgery , antibiotics , helicobacter pylori infection , microbiology and biotechnology , biology
To assess the efficacy of moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori (H. pylori) eradication.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here